Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres











Base de données
Gamme d'année
2.
Hum Mutat ; 27(10): 1062, 2006 Oct.
Article de Anglais | MEDLINE | ID: mdl-16941489

RÉSUMÉ

Léri-Weill dyschondrosteosis (LWD) is a skeletal dysplasia characterized by disproportionate short stature and Madelung deformity. Mutations or deletions of the SHOX gene have been previously identified as the main cause of LWD. We recently identified the existence of a second class of pseudoautosomal region 1 (PAR1) deletions which do not include SHOX, implicated in the etiopathogenesis of LWD. The deletions map at least 30-250 kb downstream of SHOX, are variable in size and clearly cosegregate with the LWD phenotype. In order to determine the frequency of this new type of deletions in the Spanish population we analyzed the distribution of PAR1 defects, including the screening of SHOX deletions, mutations, and PAR1 deletions downstream of SHOX, in a total of 26 LWD probands by a combination of MLPA, microsatellite analysis, SNP genotyping, dHPLC, and DNA sequencing. A molecular defect was identified in 16/26 LWD patients (61.5%): 10 PAR1 deletions downstream of SHOX, four SHOX encompassing deletions, and two SHOX mutations. No apparent phenotypic differences were observed between patients with SHOX defects and those with PAR1 deletions downstream of SHOX. In the examined cohort of Spanish LWD probands, PAR1 deletions downstream of SHOX represent the highest proportion of identified mutations (38%) compared to SHOX deletions (15%) and mutations (8%). As a consequence of our findings, the screening of this region should be included in the routine genetic testing of LWD. Also, LWD patients who tested negative for SHOX defects should be re-evaluated for PAR1 deletions downstream of SHOX.


Sujet(s)
Délétion de segment de chromosome , Protéines à homéodomaine/génétique , Ostéochondrodysplasies/génétique , Facteurs de transcription/génétique , Adolescent , Séquence d'acides aminés , Séquence nucléotidique , Enfant , Enfant d'âge préscolaire , Chromatographie en phase liquide à haute performance/méthodes , Études de cohortes , Analyse de mutations d'ADN/méthodes , Délétion de gène , Hétérogénéité génétique , Génotype , Humains , Ostéochondrodysplasies/ethnologie , Polymorphisme de nucléotide simple/génétique , Protéine homéotique associée à la petite taille , Espagne
3.
Am J Hum Genet ; 78(4): 533-42, 2006 Apr.
Article de Anglais | MEDLINE | ID: mdl-16532385

RÉSUMÉ

Williams-Beuren syndrome (WBS), caused by a heterozygous deletion at 7q11.23, represents a model for studying hypertension, the leading risk factor for mortality worldwide, in a genetically determined disorder. Haploinsufficiency at the elastin gene is known to lead to the vascular stenoses in WBS and is also thought to predispose to hypertension, present in approximately 50% of patients. Detailed clinical and molecular characterization of 96 patients with WBS was performed to explore clinical-molecular correlations. Deletion breakpoints were precisely defined and were found to result in variability at two genes, NCF1 and GTF2IRD2. Hypertension was significantly less prevalent in patients with WBS who had the deletion that included NCF1 (P=.02), a gene coding for the p47(phox) subunit of the NADPH oxidase. Decreased p47(phox) protein levels, decreased superoxide anion production, and lower protein nitrotyrosination were all observed in cell lines from patients hemizygous at NCF1. Our results indicate that the loss of a functional copy of NCF1 protects a proportion of patients with WBS against hypertension, likely through a lifelong reduced angiotensin II-mediated oxidative stress. Therefore, antioxidant therapy that reduces NADPH oxidase activity might have a potential benefit in identifiable patients with WBS in whom serious complications related to hypertension have been reported, as well as in forms of essential hypertension mediated by a similar pathogenic mechanism.


Sujet(s)
Hypertension artérielle/complications , NADPH oxidase/génétique , Syndrome de Williams/génétique , Technique de Western , Lignée de cellules transformées , Chromosomes humains de la paire 7 , Femelle , Génotype , Humains , Immunohistochimie , Mâle , Facteurs de risque , Syndrome de Williams/complications
4.
Am J Med Genet A ; 138A(3): 272-7, 2005 Oct 15.
Article de Anglais | MEDLINE | ID: mdl-16158429

RÉSUMÉ

The Simpson-Golabi-Behmel syndrome (SGBS) (OMIM 312870) is an overgrowth/multiple congenital anomalies syndrome caused by a semi-dominant X-linked gene encoding glypican 3 (GPC3). It shows great clinical variability, ranging from mild forms in carrier females to lethal forms with failure to thrive in males. The most consistent findings in SGBS are pre- and postnatal macrosomia, characteristic facial anomalies and abnormalities affecting the internal organs, skeleton, and on some occasions, mental retardation of variable degree. SGBS is also associated with an increased risk of developing embryonal tumors, mostly Wilms and liver tumors. We describe two molecularly-confirmed families with SGBS. All patients had typical manifestations of SGBS including some female relatives who had minor manifestations of the disorder. Some patients had novel findings such as a deep V-shaped sella turcica and six lumbar vertebrae. Molecular studies in affected patients showed a deletion of exon 6 in family 1 and an intronic mutation in family 2.


Sujet(s)
Malformations multiples/génétique , Faciès , Macrosomie foetale/génétique , Glypicanes/génétique , Malformations multiples/physiopathologie , Adulte , Séquence nucléotidique , Analyse cytogénétique , Femelle , Macrosomie foetale/physiopathologie , Humains , Nourrisson , Mâle , Mutation , Pedigree , Délétion de séquence , Syndrome
5.
Am J Hum Genet ; 73(1): 131-51, 2003 Jul.
Article de Anglais | MEDLINE | ID: mdl-12796854

RÉSUMÉ

Williams-Beuren syndrome (WBS) is a segmental aneusomy syndrome that results from a heterozygous deletion of contiguous genes at 7q11.23. Three large region-specific low-copy repeat elements (LCRs), composed of different blocks (A, B, and C), flank the WBS deletion interval and are thought to predispose to misalignment and unequal crossing-over, causing the deletions. In this study, we have determined the exact deletion size and LCR copy number in 74 patients with WBS, as well as precisely defined deletion breakpoints in 30 of them, using LCR-specific nucleotide differences. Most patients (95%) exhibit a 1.55-Mb deletion caused by recombination between centromeric and medial block B copies, which share approximately 99.6% sequence identity along 105-143 kb. In these cases, deletion breakpoints were mapped at several sites within the recombinant block B, with a cluster (>27%) occurring at a 12 kb region within the GTF2I/GTF2IP1 gene. Almost one-third (28%) of the transmitting progenitors were found to be heterozygous for an inversion between centromeric and telomeric LCRs. All deletion breakpoints in the patients with the inversion occurred in the distal 38-kb block B region only present in the telomeric and medial copies. Finally, only four patients (5%) displayed a larger deletion ( approximately 1.84 Mb) caused by recombination between centromeric and medial block A copies. We propose models for the specific pairing and precise aberrant recombination leading to each of the different germline rearrangements that occur in this region, including inversions and deletions associated with WBS. Chromosomal instability at 7q11.23 is directly related to the genomic structure of the region.


Sujet(s)
Délétion de gène , Mutation , Syndrome de Williams/génétique , Séquence nucléotidique , Inversion chromosomique , Chromosomes humains de la paire 7 , Amorces ADN , Humains , Hybridation fluorescente in situ , Polymorphisme de restriction
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE